0

Back to Reflex Repeat HER2 Testing of Grade 3 Breast Carcinoma at Excision Using Immunohistochemistry and In Situ Analysis: Frequency of HER2 Discordance and Utility of Core Needle Biopsy Parameters to Refine Case Selection
Reflex Repeat HER2 Testing of Grade 3 Breast Carcinoma at Excision Using Immunohistochemistry and In Situ Analysis: Frequency of HER2 Discordance and Utility of Core Needle Biopsy Parameters to Refine Case Selection

Reflex Repeat HER2 Testing of Grade 3 Breast Carcinoma at Excision Using Immunohistochemistry and In Situ Analysis: Frequency of HER2 Discordance and Utility of Core Needle Biopsy Parameters to Refine Case Selection

Online journal article in Anatomic Pathology that offers 1.0 continuing education (CME/SAM) credit that can be used to fulfill MOC Part II requirements.
  • List Price: $20.00 USD
  • Member Price: $15.00 USD

 
Want to save more?
to see if you qualify for a lower rate.
Members save $5.00 USD or more
Item Details:
Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

  • critically analyze current guidelines on HER2 testing in breast cancer in relation to repeat HER2 testing of grade 3 tumors.
  • apply refined criteria for...
Back to Reflex Repeat HER2 Testing of Grade 3 Breast Carcinoma at Excision Using Immunohistochemistry and In Situ Analysis: Frequency of HER2 Discordance and Utility of Core Needle Biopsy Parameters to Refine Case Selection
View More

Bought This Bought That ...